MannKind to Present at Jefferies Global Healthcare Conference

MannKind (Nasdaq: MNKD) announced that CEO Michael Castagna will join a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 3 at 9:20 a.m. ET.

Rhea-AI Summary

MannKind (Nasdaq: MNKD) announced that CEO Michael Castagna will join a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 3 at 9:20 a.m. ET.

Live and recorded audio webcasts will be accessible for about 90 days on MannKind’s investor relations website.

Argus May 28 session

+2.54% close to close Open Argus

Details

News Market Reaction – MNKD

In the May 28 session, MNKD gained 2.54%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights MannKind’s participation in a Jefferies Global Healthcare Conference fi...

Analysis

This announcement highlights MannKind’s participation in a Jefferies Global Healthcare Conference fireside chat on June 3, 2026, with a webcast available for about 90 days. It underscores ongoing investor-relations outreach following recent milestones in Afrezza, pipeline partnerships, and financial updates. Before this news, the stock traded below its $4.57 200-day MA and well under its 52-week high. Investors may watch how management commentary at the conference frames regulatory timelines, partnerships, and commercial execution.

Key Figures

Conference date: June 3, 2026 Presentation time: 9:20 a.m. ET Webcast availability: approximately 90 days

Conference date

June 3, 2026

Jefferies Global Healthcare Conference fireside chat

Presentation time

9:20 a.m. ET

Scheduled time of Jefferies conference fireside chat

Webcast availability

approximately 90 days

Recorded presentation accessible on investor website

Historical Context

5 past events · Latest: May 06

5 events

1. May 06

   Q1 2026 earnings

   24h Move

   -0.3%

   Reported higher Q1 2026 revenue and cash with regulatory milestones ahead.

2. May 06

   Pipeline partnership

   24h Move

   +24.5%

   Expanded ralinepag DPI program with United Therapeutics and milestone potential.

3. Apr 29

   Earnings date notice

   24h Move

   +2.9%

   Announced timing and webcast details for upcoming Q1 2026 earnings call.

4. Mar 09

   Afrezza data update

   24h Move

   +2.7%

   Presented new Afrezza pediatric and adult data and highlighted May 29 PDUFA.

5. Mar 05

   Debt settlement

   24h Move

   -7.8%

   Settled remaining 2.50% convertible notes using cash and share issuance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), announced today that Chief Executive Officer, Michael Castagna, PharmD will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on June 3 at 9:20 a.m. ET.

Links to the live audio webcast of the presentation will be available on MannKind Corporation’s website at: https://investors.mannkindcorp.com/events-and-presentations. Recorded versions will also be available on the website for approximately 90 days following the conference.

About MannKind
MannKind Corporation (Nasdaq: MNKD) is a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, we develop and commercialize treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.

With deep expertise in drug-device combinations, MannKind aims to deliver therapies designed to fit seamlessly into daily life.

Learn more at mannkindcorp.com.

Contacts:
Investor Relations
Kate Miranda
ir@mnkd.com

Media Relations
Christie Iacangelo
media@mnkd.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will MannKind (MNKD) present at the 2026 Jefferies Global Healthcare Conference?

MannKind will present at the 2026 Jefferies Global Healthcare Conference on June 3 at 9:20 a.m. ET. According to MannKind, CEO Michael Castagna will participate in a fireside chat accessible via live audio webcast on its investor website.

Who is representing MannKind (MNKD) at the 2026 Jefferies Global Healthcare Conference?

MannKind will be represented by Chief Executive Officer Michael Castagna, PharmD, in a fireside chat session. According to MannKind, investors can listen to his remarks through a live audio webcast hosted on the company’s events and presentations webpage.

How can investors access MannKind’s (MNKD) Jefferies Global Healthcare Conference webcast?

Investors can access the MannKind conference webcast via live audio on the company’s investor relations events and presentations webpage. According to MannKind, the page will provide links for the real-time session and later on-demand listening.

Will a replay of MannKind’s (MNKD) Jefferies conference presentation be available?

Yes, a recorded version of MannKind’s Jefferies Global Healthcare Conference fireside chat will be available. According to MannKind, the replay will remain on its investor relations website for approximately 90 days following the conference.

What is the stock symbol for MannKind presenting at the 2026 Jefferies Global Healthcare Conference?

The stock symbol for MannKind is MNKD, traded on Nasdaq. According to MannKind, investors can follow MNKD and access the June 3 conference webcast through the events and presentations section of its investor relations website.